NCT04608890View on ClinicalTrials.gov

Eye-tracking-based Artificial Intelligence Detects Abnormalities of the Oculomotor System in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

December 31, 2021

Conditions
Diabetic Neuropathies
Interventions
DIAGNOSTIC_TEST

Eye-tracking video test

An eye-tracking-based test will be administered to patients. It lasts 10 minutes. It consists in several screens passing by to identify objects at a certain time by a mouse clic or touchpad.

Trial Locations (1)

20157

Sacco University Hospital, Milan

All Listed Sponsors
collaborator

ASST Fatebenefratelli Sacco

OTHER

lead

University of Milan

OTHER

NCT04608890 - Eye-tracking-based Artificial Intelligence Detects Abnormalities of the Oculomotor System in Type 1 Diabetes | Biotech Hunter | Biotech Hunter